Check the time stamp on this data. Updated AI-Generated Signals for Galapagos Nv (GLPG) available here: GLPG. Type a few ...

Leerink Partners analyst Faisal Khurshid has maintained their neutral stance on GLPG stock, giving a Hold rating on December 23.Stay Ahead of ...

Galapagos (GLPG) stock is in focus as the company looks to amend its 10-year deal with Gilead (GILD) as part of plans to create a new listed unit. Read more here.

Bank of America Securities analyst Jason Gerberry maintained a Sell rating on Galapagos (GLPG – Research Report) today and set a price target ...

Galapagos NV plans to split into two entities by mid-2025, focusing on oncology cell therapy and innovative medicines, with ...

In trading on Thursday, shares of Galapagos NV (Symbol: GLPG) crossed above their 200 day moving average of $28.06, changing hands as high as $28.22 per share. Galapagos NV shares are currently ...

Galapagos (GLPG) said Wednesday that it plans to split into two entities, with a new company, or Spi Mechelen, Belgium; January 7, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG ...

Galapagos intends to create a new company with approximately €2.45 billion in cash dedicated to building a pipeline of innovative medicines through transformational transactions Galapagos will gain ...

CET; Galapagos NV. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.In addition, Galapagos ...

Galapagos intends to create a new company with approximately €2.45 billion in cash dedicated to building a pipeline of innovative medicines through transformational transactions Galapagos will gain ...

Given GLPG's returns in the past year, this is a prime example of the difficulty in investing in a biotechnology stock just because it's trading near or below cash. Remember that stock valuations ...